Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Finasteride treatment makes the prostate look more like a healthy one.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.

OXTR agonists may promote hair growth and be effective for treating hair loss.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Muscarinic acetylcholine receptors in skin cells help regulate and promote hair growth.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Finasteride may help reduce impulsivity caused by pramipexole.

Changing neuroactive steroid levels early in life can affect how adult rats respond to alcohol's stimulating effects.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Pranlukast and mirabegron may work as new diabetes drugs.

Trazodone might help reverse post finasteride syndrome.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.